Compounds > gold
Page last updated: 2024-08-22

gold and Chronic Disease

gold has been researched along with Chronic Disease in 84 studies

Research

Studies (84)

TimeframeStudies, this research(%)All Research%
pre-199065 (77.38)18.7374
1990's7 (8.33)18.2507
2000's5 (5.95)29.6817
2010's4 (4.76)24.3611
2020's3 (3.57)2.80

Authors

AuthorsStudies
Bouam, A; Drancourt, M; Goumane, A; Kaba, A; Keita, ML; Kesso Bah, M; Sagno, M; Telly Diallo, I1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Di Giulio, T; Malitesta, C; Mazzotta, E1
Braverman, I; Broza, YY; Haick, H1
Blanc, PD; Brimkulov, N; Redding-Jones, R; Vinnikov, D1
Chen, HH; Chen, HY; Cheng, JY; Lee, KL; Li, HF; Lin, H; Lin, YF; Mousavi, MZ; Wei, PK; Wong, CS1
Bose-O'Reilly, S; Devleesschauwer, B; Ericson, B; Fischer, F; Fuller, R; Hornberg, C; Krämer, A; Plass, D; Steckling, N; Winkelnkemper, J1
Bartmann, K; Kropp, R1
Amedee, RG; Ida, JB; Worley, NK1
Charlier, P; Favier, D; Huynh-Charlier, I; Keyser, C; Ludes, B; Poupon, J; Saliège, JF1
Charalambous, S; Churchyard, GJ; Corbett, EL; Day, JH; De Cock, KM; Fielding, K1
BALLABIO, CB; RATTI, G1
Bataille, C; Brenard, R; Del Natale, M; Dumortier, P; Henrion, J; Honhon, B; Peny, MO; Rahier, J; Rickaert, F; Van Den Berghe, M1
Lipsky, PE1
Cramer, CR; Eigenbrodt, EH; Hagler, HK; Meltzer, JI; Pirani, CL; Silva, FG1
Bröll, H; Tausch, G; Teherani, DK1
Siegmeth, W1
Schattenkirchner, M1
Altmann, H; Eberl, R; Tausch, G; Teherani, DK1
Ziff, M1
De Francisci, G; Magalini, SI1
Birt, D; From, L; Main, J1
Calabro, JJ1
Fukuhara, T; Kinoshita, M; Yamaji, T1
Aho, H; Kalimo, K; Mäki, J; Mustikkamki, UP; Rantala, I; Räsänen, L1
Lehner, R; Lüdtke, R; Maassen, MM; Reischl, G; Zenner, HP1
Eberl, R1
Kapeller, K; Rossmann, P; Rovenská, E1
Mathies, H1
Kahn, MF1
Flannery, EP; Herbst, KD; Stone, WH1
Chlud, K1
Helm, E1
Okada, T; Shiokawa, Y1
Faure, MH; Wiles, FJ1
Ornat, SIa1
Il'in, II; Kovalev, IuN1
Corey, PN; Eastwood, MR; McLachlan, DR; Rifat, SL1
Sheehan, JP; Sisam, DA1
Lutaĭ, AV; Rozhdestvenskaia, RSh1
Beveridge, GW; Cartwright, PH; Dalziel, K; Going, G; Marks, R; Rowell, NR1
Baran, AS; Beltran, J; Caudill, JL; Herman, LA; Hudson, PN; Kantor, SM; Noto, AM1
Holman, CD; McNulty, JC; Psaila-Savona, P; Roberts, M1
Bezuidenhout, BN; Greenacre, MJ; Sluis-Cremer, GK; Wyndham, CH1
Craft, AW1
Astaldi, A; Azzaretti, G; De Amici, M; Fornari, M; Marconi, M; Martini, A; Panzarasa, R; Plebani, A; Visconti, L1
Dale, PW; Patterson, MB1
Wawrzynska-Pagowska, J1
Anttila, R; Laaksonen, AL1
Steiger, U2
Ehrlich, GE1
Behrend, T1
Baier, H1
Miehlke, K; Wessinghage, D1
Gukelberger, M2
Miehlke, K2
Bontoux, D; Daban, M; Lefevre, JP; Medejel, A1
Altus, RE; Crasselt, C; Hunger, R; Schedwill, K1
Klotz, L; Seidel, K; Tanner, E1
Fallet, GH; Schmied, P; Van Rossum, P1
Ansell, BM1
Rau, R2
Bossa, G; Giordano, M1
Furlow, WL; Warren, MM1
Burns, SL1
Gamp, A; Schilling, A1
Hüge, W1
Nastro, LJ1
Böni, A1
Kafarnik, U; Kohlhardt, J; Miehlke, K; Wirth, B1
Burger, R; Langness, U1
Meyer, W1
Kohlhardt, I; Miehlke, K1
Hayem, F; Mozziconacci, P; Plus, A1
Muñoz Gomez, J; Rotès Querol, J1
Böhm, C1
Gross, D1
Astapenko, MG; Pavlov, VP1
Kodama, T1
Alegre Marcet, C1

Reviews

10 review(s) available for gold and Chronic Disease

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
[History and theory of therapeutic clinical research in chronic diseases, taking as example the chemotherapy of chronic pulmonary tuberculosis].
    Pneumologie (Stuttgart, Germany), 2009, Volume: 63, Issue:1

    Topics: Antitubercular Agents; Chronic Disease; Controlled Clinical Trials as Topic; Germany; Gold; History, 20th Century; History, 21st Century; Humans; Tuberculosis, Pulmonary; United States

2009
Remission-inducing therapy in rheumatoid arthritis.
    The American journal of medicine, 1983, Oct-31, Volume: 75, Issue:4B

    Topics: Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Chronic Disease; Clinical Trials as Topic; Gold; Humans; Penicillamine; Time Factors

1983
[Indications and contraindications for systemic gold therapy].
    Wiener klinische Wochenschrift. Supplementum, 1984, Volume: 156

    Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Chronic Disease; Gold; Humans; Psoriasis

1984
[Interstitial pneumopathies caused by drugs, Etiopathogenesis and therapeutic and resuscitational problems].
    Recenti progressi in medicina, 1980, Volume: 68, Issue:1

    Topics: Acute Disease; Antineoplastic Agents; Chronic Disease; Gold; Nitrofurantoin; Oxygen Inhalation Therapy; Ozone; Pituitary Hormones, Posterior; Pulmonary Fibrosis

1980
Arthritis in children.
    British journal of hospital medicine, 1985, Volume: 33, Issue:4

    Topics: Anti-Inflammatory Agents; Arthritis; Arthritis, Juvenile; Child; Child, Preschool; Chronic Disease; Combined Modality Therapy; Female; Gold; Humans; Joints; Male; Penicillamine; Physical Therapy Modalities; Prognosis; Psoriasis; Spondylitis, Ankylosing

1985
[Treatment of rheumatoid diseases].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1971, Jul-01, Volume: 24, Issue:13

    Topics: Acute Disease; Adenosine Triphosphatases; Adenosine Triphosphate; Adrenal Cortex Hormones; Arthritis, Reactive; Arthritis, Rheumatoid; Chronic Disease; Drug Synergism; Felty Syndrome; Gold; Humans; Immunosuppressive Agents; Rheumatoid Factor; Sjogren's Syndrome; Time Factors

1971
[Chronic polyarthritis. Changes--surgical and conservative treatment].
    Ergebnisse der inneren Medizin und Kinderheilkunde, 1974, Volume: 36

    Topics: Adult; Antibody Formation; Antigen-Antibody Complex; Antineoplastic Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Arthroplasty; Bone Screws; Carpal Tunnel Syndrome; Chloroquine; Chronic Disease; Female; Gold; Humans; Immunoglobulins; Joint Prosthesis; Male; Penicillamine; Radiography; Synovectomy

1974
[Current possibilities in the antiphlogistic and immunosuppressive therapy of progressive chronic polyarthritis].
    Beitrage zur Rheumatologie, 1971, Volume: 16

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Chronic Disease; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Indomethacin; Injections, Intra-Arterial; Penicillamine; Pyrazoles; Salicylates

1971
[The conservative treatment of chronic inflammatory rheumatism].
    Schweizerische medizinische Wochenschrift, 1969, Jun-28, Volume: 99, Issue:26

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Analgesics; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Child; Chronic Disease; Female; Flufenamic Acid; Gold; Humans; Immunosuppressive Agents; Indomethacin; Infant; Long-Term Care; Male; Mefenamic Acid; Middle Aged; Muscles; Oxyphenbutazone; Phenylbutazone; Physical Therapy Modalities; Prednisone; Rehabilitation; Salicylates

1969

Trials

6 trial(s) available for gold and Chronic Disease

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Remission-inducing therapy in rheumatoid arthritis.
    The American journal of medicine, 1983, Oct-31, Volume: 75, Issue:4B

    Topics: Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Chronic Disease; Clinical Trials as Topic; Gold; Humans; Penicillamine; Time Factors

1983
[Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
    Wiener klinische Wochenschrift. Supplementum, 1984, Volume: 156

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Chronic Disease; Clinical Trials as Topic; Female; Gold; Humans; Immunoglobulins; Male; Middle Aged; Radiography; Rheumatoid Factor

1984
[New methods of type II tympanoplasty in erosion of the long incus process].
    HNO, 1997, Volume: 45, Issue:3

    Topics: Auditory Threshold; Chronic Disease; Ear, Middle; Follow-Up Studies; Glass Ionomer Cements; Gold; Humans; Incus; Ossicular Prosthesis; Ossicular Replacement; Otitis Media; Prospective Studies; Prosthesis Design; Prosthesis Fitting; Titanium; Tympanoplasty

1997
Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin).
    The British journal of dermatology, 1986, Volume: 115, Issue:2

    Topics: Adolescent; Adult; Aged; Auranofin; Aurothioglucose; Chronic Disease; Clinical Trials as Topic; Female; Gold; Humans; Lupus Erythematosus, Discoid; Male; Middle Aged

1986
[On long term drug therapy of primary chronic polyarthritis].
    Die Medizinische Welt, 1967, Sep-02, Volume: 35

    Topics: Adult; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Humans; Indomethacin; Male; Middle Aged; Prednisolone; Salicylamides; Salicylates

1967

Other Studies

70 other study(ies) available for gold and Chronic Disease

ArticleYear
Gold Panning-Related Chronic Cutaneous Ulcers in Guinea, West Africa.
    The American journal of tropical medicine and hygiene, 2023, 01-11, Volume: 108, Issue:1

    Topics: Africa, Western; Buruli Ulcer; Chronic Disease; Gold; Guinea; Humans; Mycobacterium ulcerans; Skin Ulcer; Ulcer

2023
Molecularly Imprinted Polyscopoletin for the Electrochemical Detection of the Chronic Disease Marker Lysozyme.
    Biosensors, 2020, Dec-23, Volume: 11, Issue:1

    Topics: Biosensing Techniques; Chronic Disease; Electrochemical Techniques; Electrodes; Gold; Limit of Detection; Molecular Imprinting; Muramidase; Polymers

2020
Breath volatolomics for diagnosing chronic rhinosinusitis.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Adult; Aged; Breath Tests; Chronic Disease; Discriminant Analysis; Female; Gold; Humans; Male; Metabolomics; Metal Nanoparticles; Middle Aged; Nanotechnology; Nanotubes, Carbon; Rhinitis; Sinusitis; Volatile Organic Compounds; Young Adult

2018
Five-year lung function observations and associations with a smoking ban among healthy miners at high altitude (4000 m).
    Journal of occupational and environmental medicine, 2013, Volume: 55, Issue:12

    Topics: Adult; Altitude; Chronic Disease; Female; Follow-Up Studies; Forced Expiratory Volume; Gold; Humans; Hypoxia; Lung; Male; Mining; Organizational Policy; Smoking; Spirometry; Time Factors; Tobacco Smoke Pollution; Vital Capacity; Workplace; Young Adult

2013
Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip.
    The Analyst, 2015, Jun-21, Volume: 140, Issue:12

    Topics: Acute Kidney Injury; Base Pair Mismatch; Biomarkers; Chronic Disease; Gold; Humans; Lab-On-A-Chip Devices; Metal Nanoparticles; MicroRNAs; Models, Molecular; Nucleic Acid Conformation; Nucleic Acid Hybridization; Surface Plasmon Resonance

2015
Disability Weights for Chronic Mercury Intoxication Resulting from Gold Mining Activities: Results from an Online Pairwise Comparisons Survey.
    International journal of environmental research and public health, 2017, 01-10, Volume: 14, Issue:1

    Topics: Adult; Aged; Air Pollutants; Chronic Disease; Cost of Illness; Disabled Persons; Environmental Exposure; Female; Gold; Heavy Metal Poisoning; Humans; Male; Mercury; Middle Aged; Mining; Poisoning; Surveys and Questionnaires; Visual Analog Scale; Young Adult

2017
Gold laser adenoidectomy: long-term safety and efficacy results.
    International journal of pediatric otorhinolaryngology, 2009, Volume: 73, Issue:6

    Topics: Adenoidectomy; Cerebrospinal Fluid Otorrhea; Child, Preschool; Chronic Disease; Equipment Safety; Female; Gold; Humans; Infant; Laser Therapy; Male; Middle Ear Ventilation; Otitis Media with Effusion; Postoperative Complications; Prospective Studies; Time Factors; Treatment Outcome

2009
A gold elixir of youth in the 16th century French court.
    BMJ (Clinical research ed.), 2009, Dec-16, Volume: 339

    Topics: Aging; Chronic Disease; France; Gold; Hair; History, 17th Century; Poisoning

2009
HIV infection and chronic chest disease as risk factors for bacterial pneumonia: a case-control study.
    AIDS (London, England), 2003, Jul-04, Volume: 17, Issue:10

    Topics: Adult; Case-Control Studies; Chronic Disease; Disease Susceptibility; Gold; HIV Infections; HIV-1; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Mining; Occupational Diseases; Pneumonia, Bacterial; Risk Factors; Silicosis

2003
[Gold therapy with cortisone and ACTH in chronic arthropathy].
    Minerva medica, 1954, May-16, Volume: 45, Issue:39

    Topics: Adrenocorticotropic Hormone; Arthritis; Chronic Disease; Cortisone; Gold; Humans

1954
Black pigments in the liver related to gold and titanium deposits. A report of four cases.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:3

    Topics: Aged; Aged, 80 and over; Cholestasis; Chronic Disease; Female; Gold; Humans; Liver; Macrophages; Male; Middle Aged; Radiography; Titanium

2007
Chronic interstitial nephritis associated with gold therapy.
    Archives of pathology & laboratory medicine, 1983, Volume: 107, Issue:5

    Topics: Arthritis, Rheumatoid; Aurothioglucose; Chronic Disease; Electron Probe Microanalysis; Gold; Humans; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Nephritis, Interstitial

1983
[The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Wiener klinische Wochenschrift. Supplementum, 1984, Volume: 156

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Chromatin; Chronic Disease; Erythrocytes; Gold; Gold Sodium Thiomalate; Humans; Lymphocytes

1984
[Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Wiener klinische Wochenschrift. Supplementum, 1984, Volume: 156

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Chromatin; Chronic Disease; Drug Administration Schedule; Female; Gold; Gold Sodium Thiomalate; Humans; Lymphocytes

1984
Phagocytes and substrates in the joint.
    Scandinavian journal of rheumatology. Supplement, 1981, Volume: 40

    Topics: Antigen-Antibody Complex; Arthritis, Rheumatoid; Chronic Disease; Gold; Humans; Macrophages; Monocytes; Neutrophils; Synovial Membrane; Synovitis

1981
Diagnosis and management of long-standing benign oral ulceration.
    The Laryngoscope, 1980, Volume: 90, Issue:5 Pt 1

    Topics: Behcet Syndrome; Candidiasis, Oral; Chronic Disease; Diagnosis, Differential; Erythema Multiforme; Glucocorticoids; Gold; Humans; Lichen Planus; Lupus Erythematosus, Discoid; Mouth Diseases; Mouthwashes; Oral Hygiene; Pemphigus; Precancerous Conditions; Skin Diseases, Vesiculobullous; Stomatitis, Aphthous; Ulcer

1980
Management of juvenile rheumatoid arthritis.
    Comprehensive therapy, 1981, Volume: 7, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Arthritis, Juvenile; Aspirin; Child; Chloroquine; Chronic Disease; Gold; Humans; Penicillamine; Prednisone; Time Factors; Tolmetin; Uveitis, Anterior

1981
Increased capillary permeability to albumin in diabetic rat myocardium.
    Circulation research, 1993, Volume: 72, Issue:5

    Topics: Animals; Blood Vessels; Capillary Permeability; Chronic Disease; Coronary Circulation; Diabetes Mellitus, Experimental; Energy Intake; Gold; Male; Microscopy, Electron; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Serum Albumin

1993
Persistent cutaneous pseudolymphoma after intradermal gold injection.
    Journal of cutaneous pathology, 1996, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Child; Chronic Disease; Dermatitis, Allergic Contact; Female; Gold; Humans; Injections, Intradermal; Middle Aged; Pseudolymphoma; Skin Diseases

1996
[Basic treatment for chronic polyarthritis].
    Osterreichische Zeitschrift fur Stomatologie, 1977, Volume: 74, Issue:4

    Topics: Arthritis; Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Mouth Mucosa; Penicillamine

1977
Gold nephropathy in rheumatoid arthritis and in juvenile chronic arthritis.
    Czechoslovak medicine, 1979, Volume: 2, Issue:3

    Topics: Adolescent; Aged; Arthritis, Juvenile; Arthritis, Rheumatoid; Biopsy, Needle; Chronic Disease; Glomerulonephritis; Gold; Humans; Kidney; Male

1979
[Therapy of chronic polyarthritis].
    Medizinische Klinik, 1977, Aug-26, Volume: 72, Issue:34

    Topics: Adult; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Humans

1977
Medical treatment of chronic inflammatory rheumatic diseases.
    Scandinavian journal of rheumatology. Supplement, 1975, Volume: 12

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Arthritis; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Penicillamine; Rheumatic Diseases

1975
Letter: Chronic thrombocytopenia following gold therpay.
    Archives of internal medicine, 1975, Volume: 135, Issue:12

    Topics: Aged; Aurothioglucose; Chronic Disease; Female; Gold; Humans; Middle Aged; Thrombocytopenia

1975
[Pharmacotherapy of rheumatic diseases].
    Hippokrates, 1975, Volume: 46, Issue:2

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chronic Disease; Gold; Humans; Penicillamine

1975
[Experiences with gold in the treatment of chronic polyarthritis].
    Zeitschrift fur Allgemeinmedizin, 1975, Apr-20, Volume: 51, Issue:11

    Topics: Arthritis, Rheumatoid; Chronic Disease; Gold; Humans; Kidney Diseases; Skin Manifestations

1975
[Significance of drug therapy in chronic rheumatoid arthritis].
    Ryumachi. [Rheumatism], 1975, Volume: 15, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Humans; Middle Aged

1975
Chronic obstructive lung disease in gold miners.
    Inhaled particles, 1975, Volume: 4 Pt 2

    Topics: Bronchitis; Chronic Disease; Gold; Humans; Male; Maximal Midexpiratory Flow Rate; Middle Aged; Mining; Silicosis; Smoking; South Africa

1975
[A method of continuous aurotherapy for rheumatoid arthritis patients under the control of gold excretion].
    Sovetskaia meditsina, 1991, Issue:7

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chronic Disease; Dimercaprol; Feces; Female; Gold; Humans; Male; Middle Aged; Organogold Compounds; Organometallic Compounds; Propanols; Sulfhydryl Compounds; Time Factors

1991
[The chrysotherapy of patients with Reiter's disease].
    Terapevticheskii arkhiv, 1991, Volume: 63, Issue:12

    Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Reactive; Chronic Disease; Dimercaprol; Drug Evaluation; Gold; Humans; Injections, Intramuscular; Male; Middle Aged; Organogold Compounds; Organometallic Compounds; Propanols; Recurrence; Sulfhydryl Compounds

1991
Effect of exposure of miners to aluminium powder.
    Lancet (London, England), 1990, Nov-10, Volume: 336, Issue:8724

    Topics: Aluminum; Aluminum Oxide; Chronic Disease; Cognition Disorders; Cohort Studies; Evaluation Studies as Topic; Follow-Up Studies; Gold; Humans; Male; Mining; Occupational Diseases; Ontario; Powders; Prevalence; Sampling Studies; Silicosis; Time Factors; Uranium

1990
Chronic neutropenia following gold therapy.
    The Journal of the American Osteopathic Association, 1990, Volume: 90, Issue:1

    Topics: Agranulocytosis; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Humans; Middle Aged; Neutropenia

1990
[Function of the respiratory system in miners with chronic regional hypobaric hypoxia and hypothermia].
    Gigiena truda i professional'nye zabolevaniia, 1989, Issue:2

    Topics: Adaptation, Physiological; Adult; Chronic Disease; Gold; Humans; Hypothermia; Hypoxia; Male; Microclimate; Middle Aged; Mining; Pneumoconiosis; Respiratory System; Siberia; Tin; Tungsten

1989
Rheumatoid arthritis: MR imaging manifestations.
    Radiology, 1987, Volume: 165, Issue:1

    Topics: Adult; Aged; Arthritis, Rheumatoid; Arthrography; Chronic Disease; Female; Gold; Humans; Joints; Magnetic Resonance Spectroscopy; Male; Middle Aged; Time Factors

1987
Determinants of chronic bronchitis and lung dysfunction in Western Australian gold miners.
    British journal of industrial medicine, 1987, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Age Factors; Bronchitis; Child; Chronic Disease; Dust; Gold; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Mining; Occupational Diseases; Smoking; Western Australia

1987
Mortality of middle aged white South African gold miners.
    British journal of industrial medicine, 1986, Volume: 43, Issue:10

    Topics: Chronic Disease; Coronary Disease; Gold; Humans; Lung Neoplasms; Male; Middle Aged; Mining; Occupational Diseases; Respiratory Tract Diseases; Risk; South Africa; White People

1986
Immunological evaluation in children with juvenile chronic arthritis treated with auranofin.
    International journal of clinical pharmacology research, 1985, Volume: 5, Issue:3

    Topics: Antibody Formation; Arthritis, Juvenile; Auranofin; Aurothioglucose; Chemotaxis, Leukocyte; Child; Child, Preschool; Chronic Disease; Complement Activation; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Gold; Humans; In Vitro Techniques; Neutrophils; Phagocytosis; Time Factors

1985
EEG findings in chronic rheumatoid arthritics receiving gold therapy.
    Electroencephalography and clinical neurophysiology, 1967, Volume: 23, Issue:5

    Topics: Arthritis, Rheumatoid; Chronic Disease; Electroencephalography; Gold; Humans

1967
Renal disease in juvenile rheumatoid arthritis.
    Acta rheumatologica Scandinavica, 1969, Volume: 15, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Juvenile; Blood Pressure Determination; Child; Child, Preschool; Chronic Disease; Female; Gold; Hematuria; Humans; Infant; Kidney Diseases; Kidney Function Tests; Male; Proteinuria; Time Factors

1969
[Therapy of chronic polyarthritis in the practice].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1971, May-18, Volume: 60, Issue:20

    Topics: Adrenocorticotropic Hormone; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Cyclophosphamide; Gold; Humans; Indomethacin; Massage; Phenylbutazone; Physical Therapy Modalities

1971
Treatment of rheumatoid arthritis.
    JAMA, 1974, Apr-01, Volume: 228, Issue:1

    Topics: Arthritis, Rheumatoid; Chronic Disease; Gold; Hot Temperature; Humans; Hydrocortisone; Indomethacin; Injections, Intra-Articular; Oxyphenbutazone; Phenylbutazone; Remission, Spontaneous; Salts

1974
[What is assured in the treatment of chronic inflammatory joint disease?].
    Der Internist, 1972, Volume: 13, Issue:12

    Topics: Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Inflammation; Joint Diseases; Penicillamine; Physical Therapy Modalities

1972
[Panmyelophthisis induced by the treatment of primary-chronic polyarthritis with gold and D-penicillamine].
    Schweizerische medizinische Wochenschrift, 1973, Dec-22, Volume: 103, Issue:51

    Topics: Anemia, Myelophthisic; Arthritis, Rheumatoid; Aurothioglucose; Bone Marrow; Bone Marrow Examination; Chronic Disease; Female; Gold; Hematopoietic System; Humans; Liver; Methylprednisolone; Middle Aged; Penicillamine; Spleen

1973
[Modern treatment of progressive chronic polyarthritis].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1973, May-29, Volume: 62, Issue:22

    Topics: Analgesics; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Blood Transfusion; Chronic Disease; Glucocorticoids; Gold; Humans; Parasympatholytics; Physical Therapy Modalities; Recurrence

1973
[Prognosis of primary chronic polyarthritis].
    Munchener medizinische Wochenschrift (1950), 1973, Mar-16, Volume: 115, Issue:11

    Topics: Adult; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Humans; Prognosis

1973
[Neurologic complications of chrysotherapy. Apropos of 2 cases, 1 with Guillain-Barre syndrome].
    Revue du rhumatisme et des maladies osteo-articulaires, 1974, Volume: 41, Issue:1

    Topics: Arthritis, Rheumatoid; Chronic Disease; Diplopia; Female; Gold; Humans; Middle Aged; Muscular Diseases; Paresthesia; Polyradiculopathy; Reflex

1974
[Results of a rheumatic surgery study with reference to sociomedical, pharmacotherapeutic and laboratory chemical aspects].
    Zeitschrift fur arztliche Fortbildung, 1974, Volume: 68, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Analgesics; Arthritis, Rheumatoid; Arthroplasty; Blood Protein Electrophoresis; Blood Sedimentation; Chronic Disease; Disability Evaluation; Female; Follow-Up Studies; Gold; Hemoglobins; Humans; Latex Fixation Tests; Male; Physical Therapy Modalities; Socioeconomic Factors

1974
The management of juvenile chronic polyarthritis (Still's disease).
    The Practitioner, 1972, Volume: 208, Issue:243

    Topics: Adolescent; Adrenal Cortex Hormones; Antimalarials; Antineoplastic Agents; Arthritis, Juvenile; Aspirin; Child; Chronic Disease; Exercise Therapy; Female; Gold; Humans; Male; Posture; Rest

1972
[Drug therapy of progressive chronic polyarthritis].
    Therapeutische Umschau. Revue therapeutique, 1972, Volume: 29, Issue:8

    Topics: Alkylating Agents; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimalarials; Antimetabolites; Arthritis, Rheumatoid; Chronic Disease; Enzymes; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Indoles; Mefenamic Acid; Physical Therapy Modalities; Pyrazoles; Salicylates

1972
[Use of indomethacin in combination with other antirheumatic drugs in the therapy of chronic inflammatory rheumatism].
    La Clinica terapeutica, 1972, Aug-15, Volume: 62, Issue:3

    Topics: Arthritis, Rheumatoid; Aspirin; Chronic Disease; Dexamethasone; Drug Synergism; Flufenamic Acid; Gold; Humans; Hydroxychloroquine; Indomethacin; Oxyphenbutazone; Phenylbutazone; Prednisone

1972
[Treatment of chronic juvenile rheumatoid arthritis].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1971, Oct-05, Volume: 60, Issue:40

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Arthritis, Juvenile; Chronic Disease; Female; Gold; Humans; Prognosis; Salicylates

1971
Gold leaf in urologic surgery: clinical application.
    The Journal of urology, 1971, Volume: 106, Issue:4

    Topics: Adolescent; Adult; Biopsy; Child; Chronic Disease; Glomerulonephritis; Gold; Hemostatics; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Sutures; Thrombocytopenia

1971
Anemia in rheumatoid arthritis.
    The Medical clinics of North America, 1968, Volume: 52, Issue:3

    Topics: Anemia; Arthritis, Rheumatoid; Chronic Disease; Female; Gastrointestinal Hemorrhage; Glucocorticoids; Gold; Hematologic Diseases; Humans; Hypersplenism; Leukopenia; Lupus Erythematosus, Systemic; Male; Phenylbutazone; Thrombocytopenia

1968
[Critic of rheumatism therapy in the practice].
    Zeitschrift fur Rheumaforschung, 1967, Oct-13, Volume: 26, Issue:9

    Topics: Adrenal Cortex Hormones; Ambulatory Care; Arthritis, Rheumatoid; Chloroquine; Chronic Disease; Family Practice; Gold; Gout; Humans; Mineral Waters; Physical Therapy Modalities; Prednisone; Rheumatic Diseases; Salicylates; Spondylitis, Ankylosing

1967
[Experience with intravenous gold therapy in chronic rheumatic polyarthritis].
    Das Deutsche Gesundheitswesen, 1969, Dec-24, Volume: 24, Issue:52

    Topics: Adult; Aged; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Humans; Injections, Intravenous; Male; Middle Aged

1969
[Modern conception of a causal management of chronic polyarthritis].
    Deutsches medizinisches Journal, 1969, May-27, Volume: 20, Issue:10

    Topics: Antigen-Antibody Complex; Arthritis; Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Penicillamine; Rheumatoid Factor; Synovectomy

1969
Aggressive management of rheumatoid arthritis in the elderly.
    Journal of the American Geriatrics Society, 1970, Volume: 18, Issue:1

    Topics: Adrenal Cortex Hormones; Age Factors; Aged; Arthritis, Rheumatoid; Chronic Disease; Female; Gold; Hospitalization; Humans; Indomethacin; Male; Middle Aged; Rest; Salicylates

1970
[Therapy of progressive chronic polyarthritis].
    Deutsche medizinische Wochenschrift (1946), 1970, Apr-10, Volume: 95, Issue:15

    Topics: Arthritis, Rheumatoid; Chronic Disease; Cortisone; Flufenamic Acid; Gold; Humans; Indoles; Mefenamic Acid; Physical Therapy Modalities; Salicylates

1970
[Basic therapy of progressive chronic polyarthritis].
    Therapie der Gegenwart, 1970, Volume: 109, Issue:10

    Topics: Arthritis, Rheumatoid; Chronic Disease; Gold; Humans; Orthopedics

1970
[Prerequisites of gold-therapy in chronic polyarthritis].
    Medizinische Klinik, 1970, May-29, Volume: 65, Issue:22

    Topics: Albuminuria; Arthritis, Rheumatoid; Chronic Disease; Exanthema; Eye; Gold; Hemoglobinometry; Humans; Kidney; Liver; Liver Function Tests

1970
[Fatal hemorrhagic diathesis following therapy with gold].
    Medizinische Klinik, 1970, May-08, Volume: 65, Issue:19

    Topics: Arthritis, Rheumatoid; Chronic Disease; Drug Tolerance; Gold; Heart Diseases; Hemorrhagic Disorders; Humans; Kidney Diseases; Liver Cirrhosis

1970
[Basic therapy in chronic polyarthritis].
    Medizinische Klinik, 1970, May-29, Volume: 65, Issue:22

    Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cyclophosphamide; Gold; Humans; Immunosuppressive Agents; Penicillamine; Synovectomy

1970
[Treatment of chronic polyarthritis in children].
    Annales de pediatrie, 1971, Feb-02, Volume: 18, Issue:2

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Arthritis, Juvenile; Child; Child, Preschool; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Indomethacin; Salicylates

1971
[Chronic arthritis of one or both knees with rheumatoid fluid].
    Revue du rhumatisme et des maladies osteo-articulaires, 1971, Volume: 38, Issue:2

    Topics: Adult; Aged; Arthritis, Rheumatoid; Chronic Disease; Diagnosis, Differential; Female; Follow-Up Studies; Gold; Humans; Knee Joint; Leukocytes; Male; Middle Aged; Osteoarthritis; Remission, Spontaneous; Rheumatoid Factor; Synovial Fluid

1971
[The influence of gold therapy on serum glycoproteins in chronic polyarthritis].
    Deutsche medizinische Wochenschrift (1946), 1968, Jan-26, Volume: 93, Issue:4

    Topics: Adolescent; Adult; Arthritis, Rheumatoid; Child; Chronic Disease; Fucose; Glucosamine; Glycoproteins; Gold; Hexoses; Humans; Middle Aged; Mucoproteins; Neuraminic Acids; Protein Binding

1968
[Drug therapy of progressive chronic polyarthritis].
    Die Medizinische Welt, 1968, Oct-26, Volume: 43

    Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Chronic Disease; Gold; Humans; Indomethacin; Salicylates

1968
[Intra-articular corticotherapy in chronic joint diseases].
    Terapevticheskii arkhiv, 1968, Volume: 40, Issue:12

    Topics: Chloroquine; Chronic Disease; Gold; Humans; Hydrocortisone; Injections, Intra-Articular; Joint Diseases

1968
[Judgement of the therapeutic effects of non-steroid anti-inflammatory drugs in chronic rheumatoid arthritis].
    Nihon rinsho. Japanese journal of clinical medicine, 1968, Volume: 26, Issue:1

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Chronic Disease; Gold; Humans; Prednisolone

1968
[Internal therapy of chronic polyarthritis].
    Schweizerische medizinische Wochenschrift, 1969, Mar-22, Volume: 99, Issue:12

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Balneology; Chloroquine; Chronic Disease; Exercise Therapy; Gold; Humans; Immunosuppressive Agents; Muscles; Ultrasonic Therapy

1969
[Gold salts in the treatment of chronic evolutive polyarthritis].
    Revista espanola de reumatismo y enfermedades osteoarticulares, 1966, Volume: 11, Issue:8

    Topics: Arthritis, Rheumatoid; Child; Child, Preschool; Chronic Disease; Female; Gold; Humans

1966